Krystal Biotech, Inc. (KRYS)

277.20 +4.54 (+1.67%) USD  |  NASDAQ  |  Apr 22, 13:23
More

Krystal Biotech Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Scholar Rock Holding Corp. Upgrade
Stoke Therapeutics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
TG Therapeutics, Inc. Upgrade